GMS 6201 Cell Signaling Contd Lipoproteins 2024
GMS 6201 Cell Signaling Contd Lipoproteins 2024
GMS 6201 Cell Signaling Contd Lipoproteins 2024
2. Enzyme-linked
receptors
3. Cytokine receptors
4. GPCR
3. Cytokine Receptors
https://gpcrdb.org
Different G proteins mediate distinct
responses
GPCR regulation of Adenylyl Cyclase
GPCR
Phosphorylation of other
targets
• Know the difference between LDL and HDL, and why HDL is considered the
“good” form of cholesterol
Triacylglycerols
(Fats,
Triglycerides)
Fatty Acids
Phospholipid
Lipoproteins were discovered and
named by their Density
Figure 3.46 Correspondence of plasma lipoprotein density classes with electrophoretic mobility in
a plasma electrophoresis.
Reprinted with permission from Soutar, A.K., and Myant, N.B. In Offord, R.E. (Ed) Chemistry of Macromolecules, IIB. Baltimore, MD:
University Park, Press, 1979.
Textbook of Biochemistry with Clinical Correlations, 7e edited by Thomas M. Devlin © 2011 John Wiley & Sons, Inc.
Generalized structure of plasma lipoproteins
Chylomicron VLDL
Cholesterol: 3% Cholesterol : 10%
Phospholipid: 5% Phospholipid: 10%
Triacylglycerol: 90% Triacylglycerol: 70%
HDL
Cholesterol : 20%
Phospholipid: 25%
Triacylglycerol: 5% LDL
Cholesterol : 26%
Phospholipid: 15%
Triacylglycerol: 10%
ApoB: unique to non-HDL particles -- Structural and ligand for receptor binding
Mechanism of Apolipoprotein B mRNA Editing
G7m -CAA-
14.1 kb Apolipoprotein B mRNA
INTESTINE
Cytidine Deaminase
NH4+ Editing Complex
(ACTIVE)
Stop
G7m -UAA-
Translation
LIVER
INTESTINAL ApoB48 protein
Gln
G7m -CAA-
Translation
VLDL-LDL Pathway
Chylomicrons
LPL
VLDL and LDL
C
LCAT
CE
LCAT
/lecithin /lysolecithin
LCAT
LCAT
Acyl-coenzyme A:cholesterol acyltransferases
(ACAT)
HDL Particles- Reverse Cholesterol
Transport
CE
HDL
CE
C
E
C
T C
E
P E
T
T
P
P
CE CETP CE
TG
LDL VLDL
CE CETP CE
HDL Particles- Reverse Cholesterol
Transport
Sources
Target Organs
Triglyceride
and
cholesterol
Organs and pathways involved in plasma
lipoprotein metabolism
Sources
Target Organs
Triglyceride
and
cholesterol
Lipoprotein
Transport
Particle
Organs and pathways involved in plasma
lipoprotein metabolism
Sources
Triglyceride
and
cholesterol
Lipoprotein
Transport Protein component: Apolipoproteins
Particle Functions
1. Solubility, structural integrity
2. receptor binding- targeting
3. Enzyme activation
4. Exchange
Organs and pathways involved in lipoprotein metabolism
Chylomicrons
LCAT
Cholesterol and Cholesterol Plasma lipoproteins Reverse
Lecithin-cholesterol
PC esterification HDL Cholesterol
acyltransferase
transport
LPL
TG, VLDL, VLDL and chylomicron
Lipoprotein hydrolysis Capillary surface
chylomicrons degradation
Lipase
Hepatic
TG, HDL hydrolysis Liver HDL catabolism
Lipase
CETP
Plasma lipoproteins Lipoproteins
Cholesterol ester Cholesterol, TG transfer
VLDL/LDL to HDL remodeling
Transfer protein
ACAT
Cholesterol Cholesterol Liver Cholesterol uptake
AcylCoA-cholesterol
esterification LDL
acyltransferase
Overview
Lipoproteins and
Cardiovascular diseases
Diseases associated with
Lipoprotein dysfunction
• Hypolipidemia/ • Hyperlipidemia/
hypolipoproteinemia hyperlipoproteinemia
• Increased risk of
atherosclerosis and
cardiovascular diseases
Liver synthesizes
cholesterol
Atherosclerosis:
LDL hypothesis
Oxygen radicals in endothelial lining of the arteries oxidize LDL and retain them
Activated endothelial cells have increased inflammation
Macrophages take up LDL and are saturated with cholesterol thus forming foam cells
Atherosclerosis:
LDL hypothesis
HDL-Cholesterol ≥ 60 mg/dl
Abdominal Obesity
Men > 40 inch waist
Women > 35 inch waist
HDL cholesterol
Men < 40 mg/dL
Women < 50 mg/dL
Blood Pressure ≥ 130/ 85 mm Hg
Fasting Blood Glucose >110-125 mg/dL
Summary
• Distribution (Transport and Cellular Uptake) of lipids (Fatty Acids and Cholesterol) is
via Lipoproteins
• Basis for the LDL hypothesis of atherosclerosis: foam cell formation and deposition